""	"Name"	"Genes (tot)"	"Stat (dist.dir.up)"	"p (dist.dir.up)"	"p adj (dist.dir.up)"	"Stat (dist.dir.dn)"	"p (dist.dir.dn)"	"p adj (dist.dir.dn)"	"Stat (non-dir.)"	"p (non-dir.)"	"p adj (non-dir.)"	"Genes (up)"	"Stat (mix.dir.up)"	"p (mix.dir.up)"	"p adj (mix.dir.up)"	"Genes (down)"	"Stat (mix.dir.dn)"	"p (mix.dir.dn)"	"p adj (mix.dir.dn)"
"1"	"ABC transporters"	41	3.132	0.41742	1	-2.3933	0.6699	0.96626	21.55	0.014767	0.032659	23	16.167	0.049123	0.14042	18	14.248	0.091698	0.1943
"2"	"AGE-RAGE signaling pathway in diabetic complications"	98	3.188	0.54937	1	-2.0294	0.59077	0.93351	33.237	0.00057469	0.0025608	52	24.699	0.0076456	0.030086	46	22.252	0.024851	0.092961
"3"	"AMPK signaling pathway"	115	-10.277	0.99994	1	21.674	7.5108e-08	2.5286e-06	33.794	0.0017428	0.0056782	48	16.975	0.45687	0.65608	67	29.906	0.00018295	0.0042199
"4"	"Acute myeloid leukemia"	64	-5.94	0.99009	1	9.3749	0.011718	0.064554	22.818	0.097573	0.15981	30	11.722	0.65648	0.81001	34	20.296	0.014852	0.06338
"5"	"Adherens junction"	71	-10.521	0.99983	1	15.554	0.00011069	0.0014583	28.37	0.0020427	0.006515	29	13.317	0.43603	0.63825	42	25.82	0.00021844	0.0042199
"6"	"Adipocytokine signaling pathway"	68	-6.7315	0.99615	1	13.147	0.00049141	0.0049632	28.66	0.0013012	0.0045429	28	16.343	0.10455	0.2382	40	23.694	0.0025111	0.021182
"7"	"Adrenergic signaling in cardiomyocytes"	140	8.0051	0.16114	0.62597	-2.8214	0.64539	0.96626	40.167	1.5767e-05	0.00015411	78	31.912	0.00015323	0.0015477	62	24.565	0.036367	0.11244
"8"	"African trypanosomiasis"	30	9.6853	0.019614	0.1415	-8.9042	0.973	1	16.257	0.12148	0.18974	22	14.456	0.13224	0.2862	8	7.5095	0.43898	0.57087
"9"	"Alanine, aspartate and glutamate metabolism"	32	2.8768	0.42125	1	-0.56808	0.50067	0.84751	17.261	0.090083	0.14997	19	12.615	0.2152	0.39281	13	11.831	0.15325	0.26997
"10"	"Alcoholism"	100	13.524	0.004059	0.0417	-9.5708	0.97411	1	29.787	0.020024	0.041843	66	25.743	0.016439	0.057254	34	15.218	0.40054	0.5323
"11"	"Aldosterone synthesis and secretion"	93	13.628	0.0045292	0.042886	-11.242	0.98852	1	33.678	7.3358e-05	0.00056994	58	29.669	5.4312e-05	0.00068568	35	16.705	0.24434	0.36833
"12"	"Aldosterone-regulated sodium reabsorption"	36	-2.4587	0.89368	1	4.7102	0.12277	0.34891	21.836	0.0039921	0.011305	15	15.133	0.020879	0.069969	21	15.8	0.047669	0.13173
"13"	"Allograft rejection"	16	9.7391	0.01453	0.11586	-9.4412	0.98093	1	9.6506	0.46323	0.54403	15	9.2144	0.49174	0.69625	1	2.9152	0.45018	0.58293
"14"	"Alzheimer disease"	147	-2.1546	0.96736	1	4.1787	0.097541	0.28975	30.54	0.21414	0.29096	65	21.477	0.23478	0.42093	82	21.769	0.63635	0.75374
"15"	"Amino sugar and nucleotide sugar metabolism"	44	-7.6528	0.99732	1	7.6528	0.027866	0.1141	15.4	0.50941	0.59138	14	7.4272	0.68271	0.83412	30	13.577	0.52772	0.65384
"16"	"Aminoacyl-tRNA biosynthesis"	25	-7.3086	0.99135	1	7.3086	0.047168	0.17429	6.8565	0.94302	0.98632	5	0.40526	0.9482	0.99703	20	7.4632	0.91457	0.94902
"17"	"Amoebiasis"	85	6.6448	0.2032	0.72109	-2.3039	0.61321	0.93747	33.68	2.2696e-05	0.00020226	49	25.901	0.00098822	0.0065804	36	21.535	0.0076906	0.042368
"18"	"Amphetamine addiction"	65	17.19	0.00012432	0.0031392	-14.286	0.99855	1	26.85	0.0059109	0.015705	48	24.68	0.0041877	0.01866	17	11.031	0.37994	0.51393
"19"	"Amyotrophic lateral sclerosis (ALS)"	49	5.0328	0.27697	0.89278	-4.2166	0.77186	1	21.663	0.038107	0.069979	31	16.374	0.16395	0.33117	18	14.254	0.091391	0.1943
"20"	"Antigen processing and presentation"	43	4.5852	0.27473	0.89278	-4.5829	0.81374	1	12.393	0.82567	0.90316	25	11.029	0.59814	0.77102	18	6.1572	0.94727	0.97626
"21"	"Apelin signaling pathway"	131	10.357	0.049756	0.27411	-9.1841	0.96679	1	36.479	0.00075902	0.0032392	78	29.996	0.0014862	0.0087171	53	20.961	0.14173	0.25733
"22"	"Apoptosis"	129	0.97669	0.81218	1	0.71487	0.32705	0.66064	29.293	0.18208	0.25902	67	20.631	0.34844	0.55276	62	20.807	0.34855	0.48223
"23"	"Arachidonic acid metabolism"	48	10.37	0.017357	0.13148	-7.6303	0.9445	1	26.911	0.00017473	0.0010381	31	23.336	0.00065192	0.0048609	16	16.182	0.0085546	0.046287
"24"	"Arginine and proline metabolism"	46	4.5181	0.29177	0.90209	-1.3667	0.56232	0.90865	23.365	0.0067348	0.017592	24	18.726	0.006043	0.025083	22	14.227	0.18549	0.30882
"25"	"Arginine biosynthesis"	19	-8.3331	0.99673	1	8.3331	0.024159	0.1031	12.214	0.24149	0.31539	6	3.4172	0.78268	0.91963	13	12.445	0.10597	0.21568
"26"	"Arrhythmogenic right ventricular cardiomyopathy (ARVC)"	72	13.452	0.004312	0.042146	-9.7568	0.97301	1	30.397	0.00043297	0.002116	48	26.063	0.000999	0.0065804	24	15.791	0.10805	0.21568
"27"	"Ascorbate and aldarate metabolism"	14	0.47208	0.59409	1	-0.47075	0.50458	0.84938	7.2933	0.67454	0.75699	5	7.0585	0.29157	0.48317	9	3.8353	0.91339	0.94902
"28"	"Asthma"	15	11.59	0.0029743	0.036048	-10.888	0.99173	1	12.986	0.10576	0.16777	13	12.604	0.096127	0.22405	2	3.4289	0.52552	0.65384
"29"	"Autoimmune thyroid disease"	26	7.9201	0.066412	0.33538	-7.6864	0.93727	1	6.8826	0.94886	0.98632	23	6.5066	0.95197	0.99703	3	2.2458	0.78754	0.85836
"30"	"Autophagy"	122	-17.792	1	1	23.055	2.1919e-08	8.302e-07	31.384	0.025577	0.051323	40	11.234	0.89676	0.99703	82	30.435	0.00201	0.017912
"31"	"Axon guidance"	178	13.996	0.011043	0.090434	-10.361	0.97537	1	49.985	5.7854e-10	4.1559e-08	103	41.603	4.6513e-09	2.8187e-07	75	28.251	0.0076578	0.042368
"32"	"B cell receptor signaling pathway"	69	3.7048	0.4424	1	-3.6583	0.73131	1	24.009	0.057506	0.099568	39	18.065	0.14046	0.29816	30	15.814	0.22615	0.34961
"33"	"Bacterial invasion of epithelial cells"	65	-7.4375	0.99678	1	11.064	0.0034427	0.026079	21.521	0.19854	0.27596	22	12.737	0.29747	0.48722	43	17.349	0.37247	0.50609
"34"	"Basal cell carcinoma"	62	10.708	0.022328	0.15034	-5.3592	0.84153	1	33.279	3.292e-07	6.6499e-06	38	27.325	1.0036e-05	0.00019005	24	19.106	0.0072916	0.041884
"35"	"Basal transcription factors"	42	-6.581	0.9914	1	10.613	0.004722	0.030442	10.957	0.91544	0.96985	14	4.3328	0.93508	0.99703	28	10.355	0.86943	0.92434
"36"	"Base excision repair"	33	1.9948	0.48826	1	-1.9948	0.64875	0.96626	6.1128	0.99382	1	19	4.665	0.96985	1	14	3.9504	0.97606	0.99244
"37"	"Bile secretion"	63	6.5949	0.17717	0.66275	-2.6026	0.63669	0.95979	23.567	0.048614	0.08614	38	18.968	0.069525	0.17918	25	14.027	0.31633	0.4417
"38"	"Biosynthesis of unsaturated fatty acids"	24	-8.963	0.99865	1	14.476	0.00019082	0.0023127	20.427	0.0014355	0.0048327	6	11.693	0.024708	0.079642	18	16.836	0.011499	0.052791
"39"	"Bladder cancer"	38	-3.9426	0.95727	1	8.2317	0.015946	0.075492	18.238	0.10287	0.16405	17	10.537	0.43106	0.63825	21	15.053	0.082888	0.18332
"40"	"Breast cancer"	144	3.8548	0.57094	1	-0.20214	0.39555	0.76294	37.675	0.0010629	0.004009	78	27.633	0.014556	0.053138	66	25.61	0.021936	0.085212
"41"	"Butanoate metabolism"	24	-11.019	0.99982	1	19.019	1.8893e-06	4.089e-05	16.985	0.033797	0.064405	8	2.9846	0.90409	0.99703	16	18.692	0.00042298	0.006103
"42"	"C-type lectin receptor signaling pathway"	99	6.9933	0.19186	0.70042	-6.3101	0.88323	1	33.843	0.00025234	0.0013901	61	25.263	0.011231	0.041649	38	22.618	0.0041491	0.029933
"43"	"Caffeine metabolism"	4	3.8115	0.20466	0.72109	-3.8115	0.7923	1	7.9436	0.14541	0.21811	3	6.6721	0.19758	0.38035	1	4.3307	0.26218	0.38395
"44"	"Calcium signaling pathway"	182	20.965	9.7443e-06	0.00036907	-13.202	0.99608	1	50.398	2.9024e-10	4.1559e-08	122	42.315	4.0596e-08	1.9289e-06	60	27.438	0.0014814	0.014963
"45"	"Carbohydrate digestion and absorption"	36	-0.62574	0.77381	1	2.8031	0.23016	0.52076	17.644	0.10185	0.16405	20	10.67	0.5042	0.70401	16	14.536	0.039231	0.11639
"46"	"Cardiac muscle contraction"	73	3.9447	0.4025	1	-2.4118	0.65207	0.96626	21.334	0.3308	0.41198	40	16.674	0.27846	0.46873	33	13.373	0.64061	0.75528
"47"	"Cell adhesion molecules (CAMs)"	118	22.72	4.301e-07	2.3822e-05	-17.071	0.9998	1	42.576	4.4207e-09	1.6743e-07	79	39.356	2.4611e-10	3.6915e-08	39	18.044	0.18435	0.30861
"48"	"Cell cycle"	121	-0.93461	0.90819	1	4.9652	0.086397	0.27172	23.098	0.80184	0.88671	58	16.094	0.76119	0.90447	63	16.568	0.88247	0.93421
"49"	"Cellular senescence"	143	-5.2334	0.99587	1	10.163	0.003911	0.027628	34.464	0.016687	0.03586	68	20.691	0.36529	0.56851	75	27.887	0.011036	0.052246
"50"	"Central carbon metabolism in cancer"	61	-0.3879	0.81297	1	1.0837	0.32278	0.6564	21.566	0.14197	0.21402	33	14.086	0.42503	0.63441	28	16.539	0.10679	0.21568
"51"	"Chagas disease (American trypanosomiasis)"	99	5.5855	0.30701	0.93023	-0.80631	0.4862	0.84182	34.648	9.0554e-05	0.00066922	54	26.382	0.001496	0.0087171	45	22.492	0.018467	0.075615
"52"	"Chemical carcinogenesis"	47	6.0181	0.19181	0.70042	0.31509	0.40035	0.76294	26.109	0.00044269	0.0021291	26	21.216	0.0012938	0.0078401	21	15.453	0.06219	0.15075
"53"	"Chemokine signaling pathway"	172	10.346	0.074347	0.35757	-6.6025	0.87962	1	46.383	6.8178e-08	1.5891e-06	93	38.562	4.4563e-08	1.9289e-06	79	26.6	0.054851	0.14452
"54"	"Cholesterol metabolism"	48	-7.9694	0.99788	1	9.874	0.0063686	0.037837	18.496	0.21045	0.28854	21	7.481	0.87539	0.99703	27	18.063	0.030989	0.1044
"55"	"Choline metabolism in cancer"	98	-6.1947	0.99519	1	10.538	0.0049364	0.031161	32.82	0.00091421	0.0035975	43	19.403	0.095595	0.22405	55	26.653	0.0014436	0.014963
"56"	"Cholinergic synapse"	111	9.0609	0.085902	0.40095	-6.805	0.90166	1	34.207	0.00080022	0.0033676	66	27.45	0.003516	0.016141	45	20.481	0.091281	0.1943
"57"	"Chronic myeloid leukemia"	75	-5.151	0.98846	1	8.7216	0.012833	0.067041	27.404	0.0084067	0.020709	31	17.394	0.095793	0.22405	44	21.179	0.044038	0.12471
"58"	"Circadian entrainment"	94	21.272	1.7064e-06	7.3864e-05	-18.425	0.99995	1	36.176	8.1387e-06	9.1334e-05	68	33.204	3.7857e-06	8.1933e-05	26	15.088	0.18068	0.30415
"59"	"Circadian rhythm"	29	-3.6317	0.92565	1	3.6317	0.19089	0.48064	12.865	0.45272	0.53986	11	7.401	0.56898	0.76283	18	10.543	0.50805	0.63611
"60"	"Citrate cycle (TCA cycle)"	28	-14.554	1	1	17.023	2.6044e-05	0.00039457	18.619	0.020416	0.04237	5	5.0145	0.54769	0.74417	23	18.206	0.0073263	0.041884
"61"	"Cocaine addiction"	48	15.061	0.0003581	0.0077503	-12.338	0.99645	1	21.932	0.026419	0.052665	37	20.068	0.039846	0.11837	11	9.01	0.39535	0.52772
"62"	"Collecting duct acid secretion"	25	-3.192	0.90513	1	5.8048	0.088781	0.27172	12.351	0.41729	0.50576	11	7.204	0.5941	0.77102	14	10.119	0.39098	0.52419
"63"	"Colorectal cancer"	85	-1.0029	0.87374	1	2.9799	0.19355	0.4807	24.938	0.12931	0.1999	42	16.732	0.32599	0.52263	43	18.526	0.22432	0.34856
"64"	"Complement and coagulation cascades"	70	13.494	0.0029396	0.036048	-8.3002	0.95472	1	31.997	2.0802e-05	0.000191	47	26.578	0.00028008	0.0025717	23	17.827	0.010891	0.052246
"65"	"Cortisol synthesis and secretion"	62	7.2214	0.133	0.56761	-5.9972	0.87289	1	24.799	0.016425	0.035548	32	22.614	0.0012786	0.0078401	30	12.295	0.70533	0.80344
"66"	"Cushing syndrome"	151	4.1408	0.55768	1	-0.92223	0.45957	0.81912	39.271	0.00020824	0.0011905	72	31.597	0.00010255	0.0011509	79	24.129	0.24286	0.36793
"67"	"Cysteine and methionine metabolism"	45	-8.1802	0.99749	1	10.127	0.0073006	0.041737	21.069	0.039165	0.071268	15	11.522	0.20994	0.38823	30	17.656	0.076741	0.17224
"68"	"Cytokine-cytokine receptor interaction"	252	31.567	5.1328e-12	1.5552e-09	-25.454	1	1	54.959	5.935e-10	4.1559e-08	175	50.494	3.655e-10	3.6915e-08	77	23.302	0.28748	0.41283
"69"	"Cytosolic DNA-sensing pathway"	54	1.8588	0.59692	1	-1.8588	0.59522	0.93351	12.686	0.92726	0.97895	33	8.406	0.95799	0.9975	21	9.8054	0.72366	0.80988
"70"	"DNA replication"	35	-2.1071	0.87525	1	2.1071	0.25988	0.56246	8.9302	0.94088	0.98632	17	4.9648	0.95049	0.99703	18	7.6277	0.86057	0.91815
"71"	"Dilated cardiomyopathy (DCM)"	89	14.647	0.0019198	0.029085	-9.5092	0.96691	1	35.669	2.7763e-06	3.8238e-05	58	30.455	1.7696e-05	0.0002822	31	18.78	0.039045	0.11639
"72"	"Dopaminergic synapse"	126	14.93	0.001909	0.029085	-10.351	0.9816	1	40.329	2.1082e-06	3.362e-05	79	34.196	4.0743e-06	8.2302e-05	47	21.698	0.047321	0.13173
"73"	"Drug metabolism"	75	7.1159	0.15667	0.62462	1.0296	0.32212	0.6564	31.034	0.00016676	0.0010106	42	24.362	0.0016036	0.0091678	33	19.301	0.036301	0.11244
"74"	"ECM-receptor interaction"	82	18.177	2.7641e-05	0.00083752	-12.054	0.99516	1	39.546	1.4325e-09	7.2339e-08	52	35.807	6.3462e-10	4.8072e-08	30	18.237	0.050441	0.13646
"75"	"Endocrine and other factor-regulated calcium reabsorption"	45	8.8341	0.057215	0.2989	-3.39	0.70717	1	24.392	0.0023149	0.0070849	29	19.932	0.0094929	0.03641	16	14.071	0.056682	0.14555
"76"	"Endocytosis"	228	-11.283	1	1	16.405	2.2733e-05	0.00036254	40.414	0.037971	0.069979	94	22.593	0.54717	0.74417	134	33.794	0.032933	0.10783
"77"	"Endometrial cancer"	57	-4.3422	0.9703	1	6.2506	0.058628	0.20565	23.478	0.024299	0.049747	26	14.064	0.26324	0.45062	31	18.956	0.033807	0.10783
"78"	"Epstein-Barr virus infection"	171	5.8521	0.41815	1	-4.3006	0.73308	1	32.884	0.20374	0.28189	97	24.97	0.29341	0.48317	74	21.399	0.49792	0.62601
"79"	"ErbB signaling pathway"	83	-6.7333	0.99633	1	8.3979	0.01511	0.073844	26.662	0.042017	0.075333	34	15.731	0.28086	0.47017	49	21.596	0.056398	0.14555
"80"	"Estrogen signaling pathway"	131	11.789	0.020912	0.14736	-10.78	0.98618	1	30.703	0.096347	0.15866	83	26.318	0.062858	0.16707	47	17.482	0.45977	0.58534
"81"	"Ether lipid metabolism"	44	4.8756	0.26227	0.88298	-2.49	0.66126	0.96626	23.829	0.0022118	0.0068386	27	18.139	0.021014	0.069969	16	18.005	0.001047	0.011841
"82"	"Fanconi anemia pathway"	51	-1.93	0.90125	1	5.5886	0.067812	0.22779	11.626	0.95051	0.98632	25	6.7353	0.95067	0.99703	26	9.6788	0.85551	0.91597
"83"	"Fat digestion and absorption"	39	3.0337	0.44662	1	-0.15628	0.43376	0.79654	17.606	0.15325	0.22762	22	13.741	0.19137	0.37409	16	13.427	0.090347	0.1943
"84"	"Fatty acid biosynthesis"	13	-8.4038	0.99469	1	19.274	4.8809e-06	9.2431e-05	16.345	0.0055995	0.015015	5	5.1971	0.52395	0.72492	8	16.727	0.00028375	0.0046523
"85"	"Fatty acid degradation"	37	-10.515	0.99957	1	19.106	4.0503e-06	8.1815e-05	25.348	0.000131	0.00082695	12	11.925	0.10215	0.23448	25	22.575	0.00014898	0.0037617
"86"	"Fatty acid elongation"	27	-8.5602	0.99686	1	8.7297	0.016731	0.076811	18.221	0.031071	0.06035	8	9.3854	0.19548	0.37968	19	15.631	0.043739	0.12471
"87"	"Fc epsilon RI signaling pathway"	66	-4.3563	0.97485	1	5.9643	0.059048	0.20565	24.13	0.043731	0.077945	30	14.739	0.27772	0.46873	36	19.217	0.058248	0.14708
"88"	"Fc gamma R-mediated phagocytosis"	84	-3.5573	0.96471	1	7.998	0.023167	0.10028	28.792	0.0077056	0.01962	41	17.443	0.24051	0.42618	43	23.21	0.00661	0.040057
"89"	"Ferroptosis"	36	-7.6664	0.996	1	16.499	7.9746e-05	0.0010983	15.93	0.23998	0.31478	15	6.8392	0.78467	0.91963	20	17.286	0.014355	0.063037
"90"	"Fluid shear stress and atherosclerosis"	130	1.139	0.80418	1	3.7504	0.12437	0.34891	36.041	0.0011022	0.0040727	71	24.239	0.093343	0.22405	59	26.908	0.0016711	0.015344
"91"	"Focal adhesion"	195	7.5435	0.28983	0.90209	-0.5279	0.39977	0.76294	49.547	1.6759e-08	4.6163e-07	106	38.054	2.2583e-06	6.2205e-05	89	31.81	0.0010551	0.011841
"92"	"Folate biosynthesis"	21	-8.9682	0.99807	1	11.819	0.0024431	0.020563	10.854	0.48232	0.56208	7	1.3969	0.94005	0.99703	14	12.306	0.14093	0.25733
"93"	"FoxO signaling pathway"	127	-12.687	1	1	17.702	1.9393e-05	0.00032737	35.917	0.00053853	0.0024429	49	18.142	0.31247	0.50361	78	31.451	0.00022283	0.0042199
"94"	"Fructose and mannose metabolism"	29	-0.5859	0.73907	1	3.0118	0.2303	0.52076	11.437	0.63171	0.71156	14	7.6303	0.65801	0.81001	15	8.5308	0.66873	0.7717
"95"	"GABAergic synapse"	88	15.328	0.0010034	0.018728	-14.455	0.99893	1	29.43	0.0072055	0.018502	63	25.562	0.011271	0.041649	25	14.638	0.24118	0.36793
"96"	"Galactose metabolism"	27	-3.6514	0.92871	1	3.6514	0.16284	0.42536	13.664	0.33895	0.41749	13	7.0695	0.69666	0.84436	14	12.164	0.15288	0.26997
"97"	"Gap junction"	82	5.0726	0.32506	0.9466	-2.9563	0.67431	0.96626	30.881	0.0008938	0.0035975	45	24.138	0.0025149	0.012916	37	19.352	0.059535	0.149
"98"	"Gastric acid secretion"	71	12.994	0.0051848	0.043639	-9.1585	0.96803	1	27.082	0.007197	0.018502	47	23.95	0.0049993	0.021039	24	13.064	0.40314	0.53341
"99"	"Gastric cancer"	144	0.52446	0.85828	1	2.3195	0.20014	0.48481	37.825	0.00090342	0.0035975	74	25.911	0.034957	0.10699	70	27.61	0.0067792	0.040276
"100"	"Glioma"	72	1.9084	0.64402	1	-0.14375	0.41863	0.77819	26.442	0.019488	0.041006	36	20.101	0.023009	0.074965	36	17.294	0.19449	0.31683
"101"	"Glucagon signaling pathway"	96	4.796	0.36678	1	-4.2269	0.77584	1	25.711	0.16255	0.23793	53	20.375	0.1618	0.33117	43	15.797	0.59664	0.71455
"102"	"Glutamatergic synapse"	112	18.567	5.2407e-05	0.0014436	-15.285	0.99937	1	38.443	4.8935e-06	5.9309e-05	75	34.244	1.3664e-06	4.1401e-05	37	18.129	0.13608	0.25296
"103"	"Glutathione metabolism"	51	-1.0138	0.85071	1	6.5396	0.043455	0.16667	20.589	0.098355	0.16022	27	12.608	0.44054	0.64175	24	16.64	0.061066	0.15043
"104"	"Glycerolipid metabolism"	57	0.51627	0.72554	1	-0.075112	0.44002	0.79837	23.044	0.033752	0.064405	29	16.312	0.12506	0.2766	28	16.279	0.12629	0.24191
"105"	"Glycerophospholipid metabolism"	94	-2.4441	0.94566	1	8.462	0.017573	0.079471	31.149	0.0034394	0.0099251	46	20.35	0.073608	0.18586	47	25.117	0.0016158	0.0153
"106"	"Glycine, serine and threonine metabolism"	38	-2.0901	0.88819	1	6.4866	0.041613	0.16165	22.59	0.0040795	0.011445	18	14.26	0.084724	0.20703	20	17.609	0.010594	0.052246
"107"	"Glycolysis / Gluconeogenesis"	60	-0.78237	0.8459	1	2.9781	0.19194	0.48064	22.647	0.059864	0.10306	31	14.418	0.36317	0.56851	29	17.668	0.06355	0.15162
"108"	"Glycosaminoglycan biosynthesis"	53	14.129	0.0011126	0.018728	-14.127	0.99895	1	19.435	0.21156	0.28875	41	18.487	0.14718	0.3097	12	6.6727	0.77537	0.85122
"109"	"Glycosaminoglycan degradation"	19	-0.88512	0.75148	1	2.6456	0.2479	0.5443	11.944	0.27116	0.34522	7	9.6928	0.12981	0.28502	12	7.6262	0.65933	0.77134
"110"	"Glycosphingolipid biosynthesis"	43	2.031	0.53142	1	1.9561	0.28181	0.58888	20.884	0.027275	0.054015	22	15.951	0.052191	0.14779	21	13.558	0.20557	0.32957
"111"	"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"	24	-7.9076	0.99663	1	10.574	0.0042327	0.0285	13.54	0.25045	0.3243	7	5.5314	0.58641	0.76949	17	12.538	0.191	0.31453
"112"	"Glyoxylate and dicarboxylate metabolism"	29	-17.025	1	1	29.155	3.8659e-11	2.3427e-09	22.444	0.00075415	0.0032392	6	4.0281	0.71857	0.86058	23	23.144	6.6715e-06	0.00030236
"113"	"GnRH signaling pathway"	88	3.099	0.52291	1	-2.6339	0.65916	0.96626	27.585	0.032281	0.0623	46	21.252	0.03961	0.11837	42	17.688	0.29901	0.42536
"114"	"Graft-versus-host disease"	14	5.9389	0.11714	0.52977	-5.6204	0.87961	1	11.107	0.22182	0.30006	10	9.7021	0.25745	0.44576	4	5.4383	0.43212	0.56436
"115"	"HIF-1 signaling pathway"	97	-9.8552	0.99984	1	12.553	0.0012796	0.011404	24.672	0.28433	0.35896	39	11.111	0.89791	0.99703	58	22.796	0.076399	0.17224
"116"	"Hedgehog signaling pathway"	44	11.943	0.0051393	0.043639	-5.2826	0.85479	1	29.024	1.9656e-06	3.3088e-05	28	25.158	1.4973e-05	0.00025205	16	14.85	0.030137	0.1044
"117"	"Hematopoietic cell lineage"	66	9.021	0.056966	0.2989	-4.1949	0.77618	1	29.914	0.00016672	0.0010106	46	22.371	0.016418	0.057254	20	20.414	0.00044944	0.0061901
"118"	"Hepatitis B"	153	-0.52781	0.92329	1	2.0264	0.22145	0.51004	31.084	0.23096	0.30834	80	20.38	0.60562	0.77102	73	23.666	0.20323	0.32754
"119"	"Hepatitis C"	145	-3.1903	0.98129	1	7.0219	0.028522	0.11523	31.436	0.14009	0.2133	72	19.362	0.60871	0.77171	73	25.077	0.089382	0.1943
"120"	"Hepatocellular carcinoma"	162	-2.3565	0.97355	1	8.0777	0.015775	0.075492	39.534	0.00047008	0.0022255	81	25.311	0.094262	0.22405	81	30.598	0.0014664	0.014963
"121"	"Herpes simplex virus 1 infection"	157	4.1732	0.55986	1	-2.666	0.61554	0.93747	28.934	0.53781	0.61493	90	20.819	0.70621	0.84914	67	20.163	0.52869	0.65384
"122"	"Hippo signaling pathway"	154	6.1533	0.34943	0.98035	-2.4568	0.60016	0.93351	43.15	1.1965e-06	2.1325e-05	82	33.367	3.3298e-05	0.00048044	72	27.498	0.0087934	0.046744
"123"	"Histidine metabolism"	23	9.3515	0.021817	0.15024	-5.064	0.84468	1	25.245	2.6355e-06	3.8027e-05	14	21.417	1.1997e-05	0.00021383	9	13.645	0.010232	0.052246
"124"	"Homologous recombination"	39	-2.1844	0.89628	1	2.1844	0.23771	0.53354	8.0772	0.98776	1	17	4.8488	0.95426	0.99703	22	6.492	0.96831	0.99121
"125"	"Human T-cell leukemia virus 1 infection"	195	6.037	0.43377	1	-1.5182	0.48588	0.84182	39.434	0.013298	0.030296	108	30.053	0.0339	0.10481	87	25.554	0.19246	0.31521
"126"	"Human cytomegalovirus infection"	202	9.0198	0.15591	0.62462	-7.7228	0.92367	1	43.074	0.00083742	0.0034759	117	33.506	0.0042893	0.018835	85	27.091	0.064964	0.15378
"127"	"Human immunodeficiency virus 1 infection"	185	2.7884	0.73933	1	-0.82206	0.43956	0.79837	37.165	0.029164	0.057011	101	26.308	0.20403	0.38398	84	26.306	0.12463	0.24053
"128"	"Human papillomavirus infection"	309	5.8414	0.58912	1	1.3993	0.2222	0.51004	54.376	2.5806e-06	3.8027e-05	161	41.024	0.00012045	0.0012585	148	35.782	0.023987	0.09085
"129"	"Huntington disease"	163	-4.8808	0.99393	1	8.1297	0.019733	0.087929	25.825	0.91437	0.96985	77	14.694	0.98355	1	86	21.65	0.72009	0.80988
"130"	"Hypertrophic cardiomyopathy (HCM)"	85	11.471	0.018933	0.13992	-6.337	0.87849	1	32.425	0.0001287	0.00082695	52	27.443	0.00044077	0.0036095	33	17.591	0.12029	0.23515
"131"	"IL-17 signaling pathway"	87	8.8663	0.086011	0.40095	-7.9188	0.93418	1	32.298	0.0003911	0.0019751	54	25.681	0.0031392	0.014774	33	19.591	0.028669	0.1022
"132"	"Inflammatory bowel disease (IBD)"	49	7.6222	0.10154	0.46616	-1.121	0.51909	0.8642	22.835	0.015436	0.033892	32	17.596	0.08816	0.2137	17	14.626	0.048252	0.13173
"133"	"Inflammatory mediator regulation of TRP channels"	93	14.192	0.0029212	0.036048	-12.376	0.99423	1	34.619	1.9296e-05	0.00018271	60	29.927	5.1655e-05	0.0006805	33	17.763	0.1082	0.21568
"134"	"Influenza A"	141	-0.71922	0.9159	1	3.0732	0.15818	0.41934	28.723	0.35495	0.43262	75	18.229	0.7983	0.92811	66	22.55	0.19632	0.3181
"135"	"Inositol phosphate metabolism"	72	-5.6583	0.99017	1	11.419	0.0028012	0.022336	28.558	0.0030547	0.0089861	29	17.72	0.053154	0.14913	43	22.402	0.014586	0.063139
"136"	"Insulin resistance"	105	-11.398	0.99997	1	16.678	3.4491e-05	0.00049765	31.668	0.0046187	0.012608	43	14.753	0.61381	0.77462	62	28.925	0.00030708	0.0046523
"137"	"Insulin secretion"	84	12.953	0.0050502	0.043639	-6.2001	0.89455	1	35.181	3.2698e-06	4.3076e-05	55	29.025	8.793e-05	0.0010657	29	19.904	0.00951	0.049682
"138"	"Insulin signaling pathway"	132	-9.7167	0.9999	1	14.534	0.00021292	0.0024813	32.376	0.028435	0.055946	54	17.443	0.51453	0.71515	78	27.605	0.019068	0.077033
"139"	"Intestinal immune network for IgA production"	32	14.143	0.0010721	0.018728	-13.608	0.99759	1	20.1	0.011543	0.026904	26	18.468	0.017923	0.061712	6	7.973	0.22308	0.34856
"140"	"JAK-STAT signaling pathway"	148	3.3078	0.65019	1	-0.86225	0.44493	0.80246	33.398	0.053198	0.093174	90	22.044	0.55228	0.74706	58	25.892	0.0043608	0.03003
"141"	"Kaposi sarcoma-associated herpesvirus infection"	166	6.5891	0.312	0.93362	-5.2127	0.81092	1	36.606	0.018414	0.039017	97	27.185	0.098538	0.22792	69	24.546	0.078925	0.17584
"142"	"Legionellosis"	51	-0.39117	0.8079	1	4.0498	0.12779	0.35524	17.783	0.35552	0.43262	29	10.254	0.80252	0.92811	22	15.304	0.10071	0.21045
"143"	"Leishmaniasis"	53	1.5357	0.60847	1	0.90614	0.37189	0.73171	20.403	0.13175	0.20263	32	13.018	0.56615	0.76241	21	16.344	0.030532	0.1044
"144"	"Leukocyte transendothelial migration"	110	-0.37986	0.88638	1	6.3012	0.039441	0.1552	32.9	0.002839	0.0084334	58	21.821	0.11081	0.25055	52	24.806	0.0059205	0.039191
"145"	"Linoleic acid metabolism"	22	3.5369	0.31429	0.93362	-3.099	0.72734	1	15.194	0.082573	0.139	13	12.957	0.077783	0.19425	8	11.581	0.053899	0.14326
"146"	"Long-term depression"	59	1.9215	0.58521	1	1.2187	0.33498	0.67217	25.283	0.0080599	0.020018	31	18.527	0.047467	0.13829	28	17.207	0.066856	0.15464
"147"	"Long-term potentiation"	64	3.5258	0.44744	1	0.81498	0.35069	0.6945	27.505	0.0025437	0.0077073	34	20.551	0.015329	0.055293	30	18.295	0.048259	0.13173
"148"	"Longevity regulating pathway"	98	-5.1948	0.99	1	9.3607	0.010252	0.057523	28.666	0.037836	0.069979	42	17.416	0.2499	0.43768	56	22.839	0.055861	0.14555
"149"	"Lysine degradation"	58	-7.7962	0.99796	1	12.942	0.0007971	0.0075475	17.641	0.51184	0.59193	23	7.1459	0.92573	0.99703	35	16.916	0.21995	0.3471
"150"	"Lysosome"	120	-7.9029	0.99931	1	10.428	0.0039208	0.027628	25.945	0.45489	0.53986	46	15.425	0.58665	0.76949	74	20.878	0.57507	0.69293
"151"	"MAPK signaling pathway"	284	1.7259	0.88708	1	2.369	0.17702	0.45074	53.256	5.7026e-06	6.6458e-05	147	37.268	0.0023462	0.012695	137	38.073	0.00052117	0.0068658
"152"	"Malaria"	40	17.756	1.3913e-05	0.00046839	-16.001	0.9998	1	24.493	0.00054017	0.0024429	33	22.469	0.0012723	0.0078401	7	9.7646	0.13226	0.25047
"153"	"Mannose type O-glycan biosynthesis"	22	3.3617	0.33132	0.94706	-3.3617	0.74723	1	8.776	0.75279	0.83858	13	7.8656	0.59994	0.77102	9	4.2678	0.88488	0.93421
"154"	"Maturity onset diabetes of the young"	25	6.1932	0.13017	0.56344	-6.1932	0.89289	1	8.5795	0.84602	0.9221	21	6.8627	0.91293	0.99703	4	5.7245	0.39048	0.52419
"155"	"Measles"	124	2.9032	0.63857	1	-1.5656	0.52605	0.86626	29.707	0.10269	0.16405	71	20.664	0.43601	0.63825	53	21.523	0.098765	0.20782
"156"	"Melanogenesis"	96	7.2841	0.1594	0.62597	-3.5506	0.72818	1	32.966	0.00036309	0.0018647	55	26.087	0.0027738	0.013778	41	20.23	0.059993	0.149
"157"	"Melanoma"	70	3.3115	0.5113	1	-1.5312	0.53664	0.87894	26.275	0.013575	0.030696	41	18.692	0.13219	0.2862	29	18.597	0.03101	0.1044
"158"	"Metabolism of xenobiotics by cytochrome P450"	42	8.6299	0.047659	0.26742	-1.9299	0.6157	0.93747	26.15	0.0001149	0.00079342	25	22.103	0.000376	0.0032551	17	14.298	0.06199	0.15075
"159"	"MicroRNAs in cancer"	137	3.441	0.59875	1	0.19342	0.37822	0.73463	36.143	0.0013194	0.0045429	70	27.657	0.0066273	0.026774	67	23.414	0.12694	0.24191
"160"	"Mineral absorption"	39	8.5209	0.05469	0.29591	-6.1151	0.88978	1	20.472	0.02238	0.046131	22	19.205	0.0031694	0.014774	17	9.1611	0.65541	0.76972
"161"	"Mismatch repair"	22	-2.4866	0.8744	1	2.4866	0.24437	0.54424	5.1543	0.968	1	8	2.7874	0.91495	0.99703	14	4.3542	0.96644	0.99121
"162"	"Mitophagy"	61	-15.336	1	1	21.095	4.222e-07	1.163e-05	26.879	0.0026665	0.0079995	21	8.7637	0.76521	0.9057	40	26.844	3.9053e-05	0.0013148
"163"	"Morphine addiction"	90	23.326	7.3031e-08	5.5321e-06	-19.822	0.99998	1	33.254	0.00012319	0.00082695	69	31.415	0.00010846	0.0011737	21	11.898	0.42236	0.55401
"164"	"Mucin type O-glycan biosynthesis"	28	3.2664	0.37296	1	-0.41305	0.47702	0.84032	15.837	0.12566	0.19525	18	10.783	0.41826	0.62739	10	12.033	0.062927	0.15132
"165"	"N-Glycan biosynthesis"	48	-0.11698	0.76756	1	0.11633	0.41527	0.77671	15.912	0.51823	0.59705	22	11.659	0.43433	0.63825	26	10.895	0.73124	0.811
"166"	"NF-kappa B signaling pathway"	87	15.735	0.00084308	0.01703	-13.435	0.99666	1	31.417	0.0010356	0.0039721	59	27.841	0.00057196	0.0044437	28	14.965	0.26074	0.38395
"167"	"NOD-like receptor signaling pathway"	148	-2.8609	0.98063	1	6.6401	0.027346	0.1135	31.516	0.16034	0.23584	77	18.672	0.78608	0.91963	71	26.056	0.030251	0.1044
"168"	"Natural killer cell mediated cytotoxicity"	92	0.44236	0.79692	1	2.3916	0.2207	0.51004	24.303	0.25681	0.32971	50	15.758	0.64132	0.79671	42	18.775	0.17702	0.30134
"169"	"Necroptosis"	123	1.2368	0.76176	1	2.8144	0.20971	0.49872	26.43	0.43311	0.5223	67	17.871	0.70459	0.84914	56	19.623	0.36074	0.49684
"170"	"Neomycin, kanamycin and gentamicin biosynthesis"	5	-2.2232	0.77803	1	2.2232	0.31129	0.64165	6.4335	0.33822	0.41749	1	5.1806	0.20176	0.38207	4	4.6026	0.5564	0.67435
"171"	"Neuroactive ligand-receptor interaction"	316	29.944	7.6299e-10	1.1559e-07	-23.442	1	1	49.763	0.0031361	0.0091369	232	44.64	0.002467	0.012888	82	24.415	0.2623	0.38395
"172"	"Neurotrophin signaling pathway"	112	-8.7829	0.99973	1	13.016	0.00051184	0.0050028	36.24	0.00010048	0.0007249	46	21.056	0.045644	0.13427	66	29.631	0.00019949	0.0042199
"173"	"Nicotinate and nicotinamide metabolism"	28	5.6638	0.16738	0.64197	-4.4754	0.80829	1	12.624	0.45612	0.53986	19	10.415	0.47987	0.68586	9	7.1338	0.5496	0.67149
"174"	"Nicotine addiction"	40	22.531	1.9598e-08	1.9794e-06	-20.747	1	1	23.895	0.0010717	0.004009	34	24.765	0.00019712	0.0019267	6	2.7431	0.9021	0.9458
"175"	"Nitrogen metabolism"	3	-2.3237	0.78323	1	2.3237	0.27459	0.57777	5.5173	0.2952	0.37114	1	2.9311	0.44875	0.64748	2	4.6847	0.34704	0.48223
"176"	"Non-alcoholic fatty liver disease (NAFLD)"	138	-9.0386	0.99985	1	13.542	0.00030206	0.0033898	27.888	0.43439	0.5223	56	14.115	0.88288	0.99703	82	24.514	0.25051	0.37422
"177"	"Non-homologous end-joining"	12	-1.511	0.78399	1	5.2822	0.09259	0.27777	5.4998	0.79819	0.8859	6	2.6338	0.85112	0.98057	6	5.1441	0.63682	0.75374
"178"	"Non-small cell lung cancer"	65	-6.5069	0.99348	1	8.166	0.020044	0.088019	21.083	0.23898	0.31478	27	11.401	0.60311	0.77102	38	17.964	0.17925	0.30342
"179"	"Notch signaling pathway"	48	-1.7734	0.88097	1	1.7734	0.27402	0.57777	18.509	0.20917	0.28809	21	12.996	0.24426	0.43029	27	13.217	0.48112	0.60996
"180"	"Nucleotide excision repair"	43	-1.7327	0.85926	1	1.7327	0.299	0.62054	11.885	0.8661	0.93725	22	6.8852	0.92746	0.99703	21	9.9602	0.7038	0.80344
"181"	"Olfactory transduction"	38	12.656	0.0026635	0.036048	-9.8916	0.98417	1	22.515	0.0043759	0.012054	28	19.753	0.0085447	0.033193	10	10.835	0.13581	0.25296
"182"	"One carbon pool by folate"	18	-6.2086	0.9813	1	9.2878	0.012665	0.067041	12.687	0.16523	0.2407	5	6.4097	0.36822	0.56851	13	10.954	0.24186	0.36793
"183"	"Oocyte meiosis"	107	-0.54634	0.88919	1	3.3144	0.14894	0.39936	23.87	0.53354	0.61236	52	16.41	0.61612	0.77462	55	17.338	0.66767	0.7717
"184"	"Osteoclast differentiation"	111	5.6115	0.32803	0.9466	-2.25	0.60386	0.93351	33.547	0.0016415	0.0054062	64	24.975	0.026217	0.083619	47	22.411	0.026364	0.097419
"185"	"Other glycan degradation"	17	-2.2646	0.84125	1	2.2646	0.26794	0.57578	4.5817	0.94975	0.98632	7	2.0705	0.90946	0.99703	10	4.2415	0.89878	0.94559
"186"	"Other types of O-glycan biosynthesis"	22	2.4268	0.42735	1	-2.4268	0.67317	0.96626	10.179	0.59119	0.67091	11	9.4772	0.30699	0.50009	11	4.9175	0.90593	0.94654
"187"	"Ovarian steroidogenesis"	44	4.7763	0.27118	0.89278	-0.62602	0.49517	0.84751	21.611	0.018258	0.038958	26	16.848	0.05944	0.16313	18	13.54	0.14183	0.25733
"188"	"Oxidative phosphorylation"	101	-10.303	0.9999	1	11.603	0.00255	0.020882	19.79	0.88191	0.9442	37	8.3483	0.97451	1	64	18.514	0.71623	0.80977
"189"	"Oxytocin signaling pathway"	149	14.657	0.0040637	0.0417	-13.594	0.99696	1	38.333	0.00039919	0.0019828	96	32.196	0.0021487	0.011837	53	20.942	0.14334	0.25847
"190"	"PI3K-Akt signaling pathway"	329	11.259	0.12393	0.54423	-6.195	0.82447	1	54.937	1.1667e-05	0.00012626	189	42.621	0.00042286	0.0035591	140	34.697	0.03364	0.10783
"191"	"PPAR signaling pathway"	68	-5.7862	0.992	1	10.617	0.0034345	0.026079	24.818	0.03928	0.071268	33	12.877	0.58669	0.76949	35	22.089	0.0031266	0.024866
"192"	"Pancreatic cancer"	74	-6.3352	0.99636	1	8.3332	0.013575	0.068556	26.575	0.0146	0.032594	30	15.935	0.16279	0.33117	44	21.305	0.039948	0.11639
"193"	"Pancreatic secretion"	90	10.297	0.036092	0.21031	-6.5809	0.89066	1	31.217	0.0013811	0.0047019	52	27.671	0.000336	0.0029943	37	17.233	0.22355	0.34856
"194"	"Pantothenate and CoA biosynthesis"	17	-4.0754	0.93066	1	5.0727	0.10359	0.30265	16.002	0.01463	0.032594	5	11.523	0.022263	0.073323	12	11.609	0.15046	0.26817
"195"	"Parathyroid hormone synthesis, secretion and action"	104	7.3718	0.17426	0.66003	-3.5678	0.71045	1	34.035	0.00027798	0.0015041	56	27.936	0.00085936	0.0059946	48	19.924	0.16648	0.28661
"196"	"Parkinson disease"	111	-1.511	0.92738	1	3.2354	0.16495	0.42718	20.998	0.87845	0.94387	57	12.986	0.95174	0.99703	54	16.764	0.72915	0.811
"197"	"Pathways in cancer"	501	10.586	0.28076	0.89548	0.24093	0.27124	0.57777	72.028	1.8483e-11	5.6002e-09	280	53.63	3.1326e-06	7.3015e-05	221	48.083	4.4062e-05	0.0013351
"198"	"Pentose and glucuronate interconversions"	18	-0.2073	0.69077	1	0.20847	0.43025	0.79491	7.2193	0.80528	0.88727	9	4.8442	0.80009	0.92811	9	5.3654	0.78465	0.85829
"199"	"Pentose phosphate pathway"	27	-3.722	0.93116	1	8.7503	0.016538	0.076811	14.452	0.25269	0.32581	15	5.8951	0.86641	0.99065	12	15.087	0.010815	0.052246
"200"	"Peroxisome"	81	-5.9624	0.99481	1	10.317	0.0036349	0.026863	28.859	0.0049863	0.01349	35	17.364	0.15426	0.32235	46	23.149	0.010922	0.052246
"201"	"Pertussis"	65	2.9721	0.50958	1	-2.9123	0.66632	0.96626	21.179	0.22974	0.30834	37	15.737	0.35057	0.55324	28	14.178	0.36693	0.50082
"202"	"Phagosome"	114	0.59072	0.83297	1	4.2289	0.10388	0.30265	31.888	0.011417	0.026816	57	22.392	0.070925	0.18059	57	22.705	0.069453	0.15823
"203"	"Phenylalanine metabolism"	17	5.5922	0.13833	0.57415	-1.4681	0.59279	0.93351	19.889	0.00024989	0.0013901	10	15.888	0.0029831	0.014347	7	12.004	0.027418	0.09971
"204"	"Phenylalanine, tyrosine and tryptophan biosynthesis"	5	1.226	0.44627	1	-1.2277	0.60103	0.93351	7.0323	0.2692	0.34417	2	6.782	0.13934	0.29816	3	3.5411	0.62707	0.74804
"205"	"Phosphatidylinositol signaling system"	95	-3.7377	0.97772	1	8.7193	0.014006	0.069572	32.254	0.0010321	0.0039721	43	20.73	0.038972	0.11809	52	24.745	0.0063117	0.039843
"206"	"Phospholipase D signaling pathway"	142	3.8029	0.58217	1	0.33217	0.34941	0.6945	40.521	2.4015e-05	0.0002079	75	30.147	0.0005256	0.004191	67	27.094	0.0059621	0.039191
"207"	"Phosphonate and phosphinate metabolism"	6	-10.097	0.99854	1	20.763	6.6859e-07	1.5583e-05	13.543	0.0059606	0.015705	1	1.9403	0.57236	0.76399	5	13.968	0.00066509	0.0083968
"208"	"Phototransduction"	24	9.0047	0.0253	0.15971	-8.9063	0.97489	1	11.995	0.43829	0.52491	18	11.641	0.3105	0.5031	6	3.8273	0.80717	0.8766
"209"	"Platelet activation"	121	-5.3642	0.99399	1	10.41	0.0046916	0.030442	32.49	0.010887	0.025843	56	19.666	0.29201	0.48317	65	26.075	0.015895	0.066893
"210"	"Porphyrin and chlorophyll metabolism"	28	0.030807	0.70559	1	2.811	0.21327	0.50093	13.935	0.29683	0.37165	10	12.4	0.058638	0.163	18	8.1382	0.81509	0.88205
"211"	"Primary bile acid biosynthesis"	16	8.5744	0.0307	0.18604	-4.8715	0.84595	1	13.772	0.072219	0.12251	13	11.557	0.16859	0.33829	3	7.7477	0.11227	0.22234
"212"	"Primary immunodeficiency"	34	14.947	0.00024769	0.0057732	-14.944	0.99954	1	19.771	0.025391	0.051291	26	19.607	0.0066187	0.026774	8	5.412	0.72435	0.80988
"213"	"Prion diseases"	32	3.4836	0.36193	0.99694	-3.4681	0.7351	1	16.319	0.15123	0.22572	17	13.606	0.11941	0.26604	15	9.3511	0.55323	0.67321
"214"	"Progesterone-mediated oocyte maturation"	85	-4.7423	0.98256	1	9.2127	0.013058	0.067059	25.267	0.10739	0.16859	38	14.948	0.44437	0.64423	47	20.538	0.10758	0.21568
"215"	"Prolactin signaling pathway"	69	-0.38596	0.82264	1	0.46667	0.37505	0.73315	22.298	0.1578	0.23323	36	15.044	0.3728	0.56851	33	16.529	0.2155	0.34186
"216"	"Propanoate metabolism"	30	-20.276	1	1	34.587	1.1102e-15	1.1213e-13	22.162	0.0008861	0.0035975	4	0.88419	0.90143	0.99703	26	23.459	3.6459e-05	0.0013148
"217"	"Prostate cancer"	94	-2.824	0.95584	1	5.7676	0.065813	0.22406	28.289	0.036891	0.069	44	18.435	0.1747	0.34597	50	21.495	0.087241	0.19155
"218"	"Proteasome"	45	-10.589	0.99969	1	10.589	0.0054768	0.033867	12.823	0.8153	0.89506	11	3.2462	0.9371	0.99703	34	12.906	0.73338	0.811
"219"	"Protein digestion and absorption"	83	22.581	4.7173e-07	2.3822e-05	-14.574	0.99857	1	39.457	3.0535e-09	1.3217e-07	57	36.767	1.9952e-10	3.6915e-08	26	16.059	0.10255	0.21283
"220"	"Protein export"	21	-3.1741	0.9079	1	3.1741	0.20035	0.48481	4.0306	0.98431	1	10	-0.16162	0.99648	1	11	5.7231	0.8425	0.90846
"221"	"Protein processing in endoplasmic reticulum"	154	-6.0425	0.99841	1	7.0948	0.025889	0.10895	21.379	0.99438	1	66	11.656	0.99385	1	88	18.188	0.97508	0.99244
"222"	"Proteoglycans in cancer"	196	6.2865	0.41579	1	-2.5548	0.57166	0.91647	45.722	1.4644e-05	0.00014791	103	35.517	9.1715e-05	0.0010688	93	28.999	0.033771	0.10783
"223"	"Proximal tubule bicarbonate reclamation"	20	4.6496	0.22262	0.77532	-1.7284	0.60138	0.93351	13.297	0.17995	0.25719	13	10.619	0.25733	0.44576	7	8.0056	0.31417	0.44119
"224"	"Purine metabolism"	122	14.441	0.0041287	0.0417	-10.581	0.98011	1	34.577	0.0011894	0.0043421	80	29.171	0.0047425	0.020528	42	18.671	0.18708	0.30975
"225"	"Pyrimidine metabolism"	53	4.9386	0.26581	0.88506	-4.3692	0.80717	1	17.249	0.46616	0.54535	33	13.52	0.50085	0.70258	20	10.714	0.5763	0.69293
"226"	"Pyruvate metabolism"	36	-14.049	0.99999	1	24.935	8.1786e-09	3.5401e-07	21.764	0.004282	0.011903	13	4.3246	0.92174	0.99703	23	23.977	1.4551e-06	0.00011022
"227"	"RIG-I-like receptor signaling pathway"	61	-0.02512	0.78643	1	0.024932	0.4115	0.77671	17.223	0.62927	0.71145	37	9.7851	0.93288	0.99703	24	15.309	0.14416	0.25847
"228"	"RNA degradation"	76	-7.7647	0.99839	1	10.762	0.0040761	0.028069	16.524	0.88499	0.9442	29	6.792	0.97692	1	47	15.677	0.71608	0.80977
"229"	"RNA polymerase"	26	-4.724	0.95774	1	7.286	0.046781	0.17429	6.0485	0.97167	1	13	-0.18984	0.99814	1	13	8.7437	0.54451	0.66796
"230"	"RNA transport"	146	-12.253	1	1	13.334	0.00041324	0.0043177	16.902	0.99991	1	49	4.6029	0.99998	1	97	17.464	0.99584	0.99997
"231"	"Rap1 signaling pathway"	199	0.80101	0.87891	1	5.3318	0.065103	0.22406	46.551	1.0147e-06	1.9215e-05	108	31.379	0.01119	0.041649	90	35.713	2.7491e-06	0.0001666
"232"	"Ras signaling pathway"	218	8.2306	0.2308	0.79468	-5.236	0.80234	1	50.616	3.3612e-08	8.487e-07	123	38.9	2.0121e-05	0.00030483	94	33.431	0.00030037	0.0046523
"233"	"Regulation of actin cytoskeleton"	208	2.2653	0.78823	1	4.2192	0.10831	0.31254	42.542	0.0014912	0.0049651	113	29.756	0.062095	0.1665	94	31.504	0.0033513	0.025386
"234"	"Regulation of lipolysis in adipocytes"	52	-0.47779	0.80121	1	4.4574	0.1235	0.34891	26.878	0.00047817	0.002229	27	17.743	0.028825	0.090979	25	20.325	0.0026308	0.021544
"235"	"Relaxin signaling pathway"	127	4.4911	0.47565	1	-1.0483	0.49052	0.84447	36.721	0.00020107	0.0011716	69	27.602	0.0068804	0.027431	58	24.232	0.023661	0.090751
"236"	"Renal cell carcinoma"	66	-9.9486	0.99971	1	13.81	0.00039521	0.0042768	25.929	0.010917	0.025843	24	13.368	0.26819	0.45652	42	22.398	0.011954	0.053297
"237"	"Renin secretion"	63	10.473	0.023627	0.15563	-8.0529	0.94608	1	28.869	0.00034341	0.0018255	41	23.858	0.0024149	0.012837	22	16.283	0.052005	0.13945
"238"	"Renin-angiotensin system"	20	3.5177	0.32401	0.9466	-0.59649	0.49852	0.84751	11.765	0.34144	0.41885	13	8.72	0.48899	0.6956	7	8.003	0.31451	0.44119
"239"	"Retinol metabolism"	35	1.6059	0.56412	1	2.8113	0.21068	0.49872	18.699	0.052321	0.09217	19	13.475	0.14072	0.29816	16	12.972	0.12184	0.23664
"240"	"Retrograde endocannabinoid signaling"	138	10.808	0.040994	0.23436	-9.5729	0.97654	1	34.277	0.012027	0.027817	81	29.105	0.0049335	0.021039	57	18.638	0.54149	0.66696
"241"	"Rheumatoid arthritis"	69	8.7277	0.07226	0.35757	-6.1633	0.88194	1	28.296	0.0013056	0.0045429	40	24.15	0.00087051	0.0059946	29	15.283	0.2573	0.38217
"242"	"Riboflavin metabolism"	8	0.86532	0.52129	1	4.0396	0.16672	0.42809	11.678	0.057078	0.099395	5	7.556	0.23837	0.42485	3	9.3157	0.036886	0.11289
"243"	"Ribosome"	126	2.6189	0.66355	1	-2.6189	0.62906	0.95303	7.8945	1	1	88	4.2925	1	1	38	7.8433	0.99764	0.99997
"244"	"Ribosome biogenesis in eukaryotes"	74	-5.9748	0.99509	1	5.9748	0.050257	0.18347	10.249	0.99947	1	29	3.4847	0.99899	1	45	10.346	0.99316	0.99997
"245"	"SNARE interactions in vesicular transport"	31	-10.127	0.99935	1	12.474	0.0016482	0.014269	15.629	0.1974	0.27596	6	6.5542	0.39755	0.59929	25	14.193	0.29491	0.4215
"246"	"Salivary secretion"	72	13.223	0.005129	0.043639	-5.6498	0.84517	1	35.89	1.7946e-07	3.884e-06	47	29.799	3.0663e-06	7.3015e-05	25	20.049	0.0035802	0.026459
"247"	"Salmonella infection"	77	-2.9956	0.94849	1	5.4152	0.082121	0.26192	23.355	0.16984	0.24466	35	15.483	0.34158	0.54473	41	18.983	0.13585	0.25296
"248"	"Selenocompound metabolism"	16	-10.85	0.99957	1	17.382	1.9448e-05	0.00032737	13.376	0.092042	0.1524	2	2.1605	0.6603	0.81001	14	13.483	0.065962	0.15464
"249"	"Serotonergic synapse"	99	13.815	0.0040499	0.0417	-10.11	0.97921	1	33.566	0.00035329	0.0018456	66	28.057	0.0018939	0.010627	33	18.46	0.068187	0.15652
"250"	"Signaling pathways regulating pluripotency of stem cells"	137	-3.6696	0.98529	1	4.9176	0.08054	0.26192	32.502	0.036885	0.069	69	19.736	0.53367	0.73501	68	26.253	0.017035	0.070708
"251"	"Small cell lung cancer"	90	-2.0973	0.93228	1	5.2598	0.088717	0.27172	26.727	0.065572	0.11225	42	17.765	0.21509	0.39281	48	19.98	0.16134	0.28095
"252"	"Sphingolipid metabolism"	46	-1.0369	0.82759	1	2.9614	0.2016	0.48481	18.545	0.18896	0.26755	22	12.174	0.36685	0.56851	24	14.019	0.27674	0.40121
"253"	"Sphingolipid signaling pathway"	117	-1.9061	0.94497	1	6.7906	0.033898	0.13515	36.02	0.00011522	0.00079342	51	25.901	0.0027199	0.013736	66	25.189	0.031736	0.10567
"254"	"Spliceosome"	127	-6.1912	0.997	1	6.1912	0.05444	0.19637	12.796	1	1	49	6.2682	0.99977	1	78	11.36	0.99997	0.99997
"255"	"Staphylococcus aureus infection"	37	3.0692	0.42236	1	4.2061	0.13448	0.37044	21.206	0.010648	0.025605	23	13.989	0.18262	0.35932	14	16.544	0.0043254	0.03003
"256"	"Starch and sucrose metabolism"	24	-1.7743	0.84561	1	2.3167	0.24608	0.54424	15.883	0.072376	0.12251	11	10.4	0.21013	0.38823	13	12.014	0.13792	0.25481
"257"	"Steroid biosynthesis"	18	-17.828	1	1	36.303	0	0	26.617	8.2642e-09	2.7823e-07	4	7.1855	0.19834	0.38035	14	26.34	2.7081e-10	8.2055e-08
"258"	"Steroid hormone biosynthesis"	36	-1.2302	0.81982	1	5.5856	0.087643	0.27172	16.008	0.23205	0.30838	18	10.197	0.49622	0.69932	18	12.443	0.25071	0.37422
"259"	"Sulfur metabolism"	8	-12	0.99975	1	21.237	5.9155e-07	1.4937e-05	14.094	0.009278	0.02249	1	0.43922	0.74339	0.8868	7	14.901	0.0015358	0.015011
"260"	"Sulfur relay system"	8	-6.0858	0.97167	1	10.705	0.0066566	0.038788	6.3742	0.54807	0.62431	2	0.02604	0.86531	0.99065	6	7.3453	0.30324	0.42936
"261"	"Synaptic vesicle cycle"	76	2.4113	0.59196	1	5.3641	0.077964	0.25677	26.825	0.015623	0.034056	41	18.947	0.11506	0.25825	35	19.023	0.058042	0.14708
"262"	"Synthesis and degradation of ketone bodies"	9	-9.255	0.99599	1	22.319	2.4706e-07	7.4858e-06	17.057	0.00067699	0.0029729	3	3.5518	0.58918	0.76949	6	18.379	6.1271e-07	8.3381e-05
"263"	"Systemic lupus erythematosus"	31	6.4608	0.12169	0.54225	-5.5624	0.86732	1	18.573	0.034342	0.065034	20	15.123	0.069487	0.17918	11	10.788	0.17045	0.29179
"264"	"T cell receptor signaling pathway"	98	3.4187	0.5253	1	-3.1135	0.6815	0.96945	31.988	0.0021983	0.0068386	56	22.861	0.060938	0.16486	42	22.465	0.011208	0.052246
"265"	"TGF-beta signaling pathway"	87	6.3812	0.23466	0.79889	-5.2157	0.82053	1	27.198	0.0407	0.073406	48	22.299	0.031787	0.099293	39	15.885	0.45917	0.58534
"266"	"TNF signaling pathway"	107	7.0983	0.2045	0.72109	-4.0041	0.73821	1	31.547	0.0078821	0.019738	62	24.751	0.021012	0.069969	45	19.593	0.15867	0.2779
"267"	"Taste transduction"	52	10.916	0.016594	0.12892	-7.0354	0.91861	1	22.718	0.025053	0.050946	39	17.78	0.16304	0.33117	13	14.64	0.019939	0.079494
"268"	"Taurine and hypotaurine metabolism"	11	7.0425	0.063235	0.32475	-6.0467	0.89992	1	9.9218	0.231	0.30834	8	9.6589	0.17097	0.34082	3	3.2259	0.66982	0.7717
"269"	"Terpenoid backbone biosynthesis"	22	-17.035	1	1	33.747	8.8818e-16	1.1213e-13	20.294	0.0012064	0.0043518	5	0.30259	0.95166	0.99703	17	22.923	8.2556e-07	8.3381e-05
"270"	"Th1 and Th2 cell differentiation"	77	7.4288	0.13642	0.57409	-5.8945	0.87066	1	27.487	0.0085658	0.020931	49	20.908	0.078213	0.19425	28	17.924	0.038023	0.11521
"271"	"Th17 cell differentiation"	91	5.3473	0.30538	0.93023	-3.6734	0.74147	1	30.187	0.003919	0.011202	53	22.432	0.048516	0.14	38	20.223	0.039717	0.11639
"272"	"Thermogenesis"	197	-9.5292	0.99997	1	11.459	0.0012752	0.011404	29.144	0.87186	0.94011	81	15.282	0.97879	1	116	25.21	0.76328	0.841
"273"	"Thiamine metabolism"	13	2.0513	0.41501	1	-2.0517	0.66196	0.96626	10.727	0.23483	0.31071	7	8.4932	0.22983	0.41452	6	6.6161	0.40961	0.53962
"274"	"Thyroid cancer"	36	3.6109	0.34736	0.98035	-0.30255	0.48024	0.84111	17.683	0.099573	0.16134	19	14.373	0.084045	0.20703	17	10.538	0.45249	0.58342
"275"	"Thyroid hormone signaling pathway"	114	8.2732	0.14366	0.58824	-4.1337	0.73737	1	33.769	0.001926	0.0062084	63	28.088	0.00083894	0.0059946	51	19.27	0.28062	0.40489
"276"	"Thyroid hormone synthesis"	73	10.099	0.030404	0.18604	-6.335	0.90037	1	24.194	0.084416	0.14132	47	20.717	0.06678	0.17595	26	12.686	0.48533	0.61273
"277"	"Tight junction"	158	-3.8972	0.98886	1	9.9502	0.0056504	0.034242	40.933	7.8461e-05	0.00059434	67	29.035	0.00065775	0.0048609	91	29.022	0.027642	0.09971
"278"	"Toll-like receptor signaling pathway"	94	1.5402	0.71037	1	-0.048123	0.41491	0.77671	24.06	0.33176	0.41198	53	16.244	0.64158	0.79671	41	17.961	0.23408	0.36003
"279"	"Toxoplasmosis"	95	-2.502	0.95295	1	6.0123	0.056082	0.19991	29.666	0.012567	0.028846	47	18.525	0.22036	0.39982	48	23.404	0.011961	0.053297
"280"	"Transcriptional misregulation in cancer"	158	11.65	0.035241	0.20938	-7.4668	0.91182	1	41.062	6.639e-05	0.00052937	99	32.028	0.0037921	0.01715	59	25.708	0.0065494	0.040057
"281"	"Tryptophan metabolism"	42	-6.0802	0.98774	1	15.199	0.00012999	0.0016412	26.924	4.0471e-05	0.00034063	17	14.764	0.059761	0.16313	25	22.723	0.00012066	0.0033238
"282"	"Tuberculosis"	147	-0.60336	0.92307	1	3.112	0.14651	0.39635	31.856	0.10675	0.16847	78	20.422	0.58864	0.76949	69	24.784	0.066588	0.15464
"283"	"Type I diabetes mellitus"	21	11.6	0.0039615	0.0417	-11.341	0.99332	1	14.154	0.13425	0.20544	18	13.098	0.16265	0.33117	3	5.365	0.3658	0.50082
"284"	"Type II diabetes mellitus"	45	-0.69147	0.80942	1	5.3738	0.082016	0.26192	24.943	0.0013088	0.0045429	21	17.323	0.016188	0.057254	24	17.951	0.021564	0.084857
"285"	"Tyrosine metabolism"	31	2.28	0.47528	1	3.1203	0.20127	0.48481	24.157	0.00012626	0.00082695	16	17.638	0.0028293	0.013827	15	16.511	0.0060792	0.039191
"286"	"Ubiquinone and other terpenoid-quinone biosynthesis"	11	-5.4849	0.96225	1	9.4238	0.012701	0.067041	10.592	0.17037	0.24466	3	5.1012	0.37876	0.57382	8	9.2959	0.21425	0.34167
"287"	"Ubiquitin mediated proteolysis"	131	-4.4595	0.99104	1	6.2019	0.044653	0.16912	23.26	0.86544	0.93725	58	14.106	0.91639	0.99703	73	18.585	0.84683	0.90989
"288"	"VEGF signaling pathway"	58	-4.9568	0.98249	1	5.0072	0.089866	0.2723	20.327	0.19551	0.27553	27	11.162	0.63414	0.79398	31	17.387	0.10763	0.21568
"289"	"Valine, leucine and isoleucine degradation"	45	-19.264	1	1	30.948	9.3769e-13	7.103e-11	27.54	5.9865e-05	0.00049025	8	7.8024	0.37337	0.56851	37	26.744	6.9852e-06	0.00030236
"290"	"Vascular smooth muscle contraction"	124	5.657	0.36063	0.99694	-1.377	0.5094	0.85276	39.032	4.0104e-06	5.0631e-05	68	30.162	0.00025807	0.0024436	55	26.177	0.0025167	0.021182
"291"	"Vasopressin-regulated water reabsorption"	42	0.92799	0.64908	1	-0.91447	0.52402	0.86626	17.63	0.1985	0.27596	23	12.301	0.37226	0.56851	19	12.678	0.26796	0.39035
"292"	"Viral carcinogenesis"	156	3.2699	0.64236	1	-0.80747	0.45417	0.81428	29.501	0.45842	0.54047	77	23.448	0.20724	0.38761	79	18.307	0.92344	0.95495
"293"	"Viral myocarditis"	38	2.9448	0.44039	1	-2.7515	0.67607	0.96626	16.128	0.2755	0.34927	25	11.002	0.60151	0.77102	13	12.317	0.11482	0.22592
"294"	"Vitamin B6 metabolism"	6	-3.9245	0.90929	1	3.9245	0.15915	0.41934	4.1611	0.69199	0.7737	1	0.92773	0.6916	0.84159	5	4.1434	0.68562	0.7869
"295"	"Vitamin digestion and absorption"	23	-1.2926	0.78748	1	4.4073	0.14199	0.38761	13.331	0.24614	0.32009	9	9.2487	0.26309	0.45062	14	9.6709	0.45509	0.58428
"296"	"Wnt signaling pathway"	150	6.7933	0.28886	0.90209	-2.1053	0.56167	0.90865	41.594	1.4331e-05	0.00014791	79	32.762	3.5607e-05	0.00049041	71	25.9	0.034503	0.1089
"297"	"alpha-Linolenic acid metabolism"	22	0.66497	0.61561	1	-0.22709	0.47523	0.84032	13.849	0.17006	0.24466	12	10.682	0.20034	0.38179	9	12.054	0.042631	0.12302
"298"	"beta-Alanine metabolism"	31	1.2885	0.57924	1	2.3594	0.25267	0.55078	21.69	0.002205	0.0068386	13	17.869	0.0012055	0.0077717	18	13.279	0.16427	0.28443
"299"	"cAMP signaling pathway"	207	15.987	0.0028339	0.036048	-9.8221	0.97001	1	50.9	1.0982e-08	3.3275e-07	130	41.179	1.2332e-06	4.1401e-05	77	29.95	0.00080268	0.0097285
"300"	"cGMP-PKG signaling pathway"	159	11.735	0.02516	0.15971	-2.1787	0.56378	0.90865	47.691	6.8579e-10	4.1559e-08	95	37.777	1.2079e-06	4.1401e-05	64	29.145	0.00029682	0.0046523
"301"	"mRNA surveillance pathway"	84	-3.9763	0.97253	1	5.7891	0.068413	0.22779	14.689	0.98542	1	32	9.0837	0.92941	0.99703	52	11.543	0.99186	0.99997
"302"	"mTOR signaling pathway"	151	-16.749	1	1	23.254	2.6031e-09	1.3145e-07	35.905	0.0077906	0.019671	50	16.524	0.54389	0.74417	101	32.275	0.0032005	0.024866
"303"	"p53 signaling pathway"	66	8.5327	0.073305	0.35757	-6.1431	0.88583	1	22.169	0.14186	0.21402	40	19.29	0.06978	0.17918	26	11.395	0.66795	0.7717
